Skip to main content
Log in

Natriuretic peptides in acute pulmonary embolism: a systematic review

  • Review
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

Abstract

Background

Patients with pulmonary embolism (PE) have a high risk of death, and it is important to recognize factors associated with higher mortality. Recently, several biomarkers have been studied for risk stratification in patients with PE.

Objectives

Evaluate the available evidence on (a) the accuracy of brain natriuretic peptide (BNP) and N-terminal pro-brain natriuretic peptide (NT-proBNP) for the diagnosis of right ventricular dysfunction and (b) their value as a prognostic factor of all-cause in-hospital or short-term mortality in patients with PE.

Data sources

MEDLINE, Embase, and citation review of relevant primary and review articles.

Selection criteria

We selected studies evaluating the accuracy of BNP or NT-proBNP for the diagnosis of right ventricular dysfunction. We also selected studies that reported data on BNP or NT-proBNP as a predictor of short-term mortality in patients with PE.

Results

Sixteen studies met our inclusion criteria. The pooled diagnostic odds ratio for the diagnosis of right ventricular dysfunction in pulmonary embolism was 39.45 (95% CI; 15.54–100.12) and 24.73 (95% CI 2.02–302.37) for BNP and NT-proBNP, respectively. The pooled odds ratio for all-cause in-hospital or short-term mortality was 6 (95% CI 1.31–27.43; p: 0.021) and 16.12 (95% CI 3.1–83.68; p: 0.001) for BNP (cutoff: 100 pg/ml) and NT-proBNP (cutoff: 600 ng/L), respectively.

Conclusion

The results of this meta-analysis indicate that BNP and NT-proBNP are associated with the diagnosis of right ventricular dysfunction (RVD) in patients with an acute PE and are significant predictors of all-cause in-hospital or short-term mortality in these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Heit JA, Melton LJ 3rd, Lohse CM, Petterson TM, Silverstein MD, Mohr DN, O’Fallon WM (2001) Incidence of venous thromboembolism in hospitalized patients vs community residents. Mayo Clin Proc 76:1102–1110

    Article  PubMed  CAS  Google Scholar 

  2. Piazza G, Goldhaber SZ (2006) Acute pulmonary embolism: part I: epidemiology and diagnosis. Circulation 114:e28–e32

    Article  PubMed  Google Scholar 

  3. Goldhaber SZ, Visani L, De Rosa M (1999) Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 353:1386–1389

    Article  PubMed  CAS  Google Scholar 

  4. Konstantinides S (2005) Pulmonary embolism: impact of right ventricular dysfunction. Curr Opin Cardiol 20:496–501

    Article  PubMed  Google Scholar 

  5. Kaczynska A, Pelsers MM, Bochowicz A, Kostrubiec M, Glatz JF, Pruszczyk P (2006) Plasma heart-type fatty acid binding protein is superior to troponin and myoglobin for rapid risk stratification in acute pulmonary embolism. Clin Chim Acta 371:117–123

    Article  PubMed  CAS  Google Scholar 

  6. Levin ER, Gardner DG, Samson WK (1998) Natriuretic peptides. N Engl J Med 339:321–328

    Article  PubMed  CAS  Google Scholar 

  7. Weber M, Hamm C (2006) Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine. Heart 92:843–849

    Article  PubMed  CAS  Google Scholar 

  8. Irwig L, Macaskill P, Glasziou P, Fahey M (1995) Meta-analytic methods for diagnostic test accuracy. J Clin Epidemiol 48:119–130

    Article  PubMed  CAS  Google Scholar 

  9. Walter SD (2002) Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data. Stat Med 21:1237–1256

    Article  PubMed  CAS  Google Scholar 

  10. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, Lijmer JG, Moher D, Rennie D, de Vet HC (2003) Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. BMJ 326:41–44

    Article  PubMed  Google Scholar 

  11. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP (2007) Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 335:806–808

    Article  Google Scholar 

  12. Zamora J, Abraira V, Muriel A, Khan K, Coomarasamy A (2006) Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol 6:31

    Article  PubMed  Google Scholar 

  13. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188

    Article  PubMed  CAS  Google Scholar 

  14. Egger M, Smith GD, Altman DG (2001) Systematic reviews in health care, 2nd edn. BMJ, London

    Google Scholar 

  15. Morgan M, Kalantri S, Flores L, Pai M (2005) A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. BMC Infect Dis 5:62

    Article  PubMed  CAS  Google Scholar 

  16. Moses LE, Shapiro D, Littenberg B (1993) Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med 12:1293–1316

    PubMed  CAS  Google Scholar 

  17. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719–748

    PubMed  CAS  Google Scholar 

  18. Lee SJ, Lee JH, Park JY, Jo WS, Kim JE, Kim KU, Park HK, Kim YS, Lee MK, Park SK (2006) The prognostic role of B-type natriuretic peptide in acute pulmonary thromboembolism. Tuberc Respir Dis 60:540–547

    Article  Google Scholar 

  19. Yetkin O, Aksoy Y, Turhan H, In E, Karahan M, Kilic T, Hacievliyagil SS, Gunen H (2007) Value of plasma BNP levels as a prognostic marker in lung and heart disorders. Tuberk Toraks 55:225–230

    PubMed  Google Scholar 

  20. Kaczynska A, Pelsers MM, Bochowicz A, Kostrubiec M, Glatz JF, Pruszczyk P (2006) Plasma heart-type fatty acid binding protein is superior to troponin and myoglobin for rapid risk stratification in acute pulmonary embolism. Clin Chim Acta 371:117–123

    Article  PubMed  CAS  Google Scholar 

  21. Kucher N, Walpoth N, Wustmann K, Noveanu M, Gertsch M (2003) QR in V1—an ECG sign associated with right ventricular strain and adverse clinical outcome in pulmonary embolism. Eur Heart J 24:1113–1119

    Article  PubMed  Google Scholar 

  22. Enea I, Ceparano G, Mazzarella G, Di Sarno R, Cangiano G, Busino CA (2004) Biohumoral markers and right ventricular dysfunction in acute pulmonary embolism: the answer to thrombolytic therapy. Ital Heart J 5(1 Suppl):29–35

    Google Scholar 

  23. Sohne M, Ten Wolde M, Boomsma F, Reitsma JB, Douketis JD, Buller HR (2006) Brain natriuretic peptide in hemodynamically stable acute pulmonary embolism. J Thromb Haemost 4:552–556

    Article  PubMed  CAS  Google Scholar 

  24. Pascu AM, Radoi M, Coculescu M (2005) Plasma brain natriuretic peptide (BNP) increase is associated with acute right ventricular dysfunction in pulmonary embolism. Acta Endocrinol 1:393–410

    CAS  Google Scholar 

  25. Kiely DG, Kennedy NS, Pirzada O, Batchelor SA, Struthers AD, Lipworth BJ (2005) Elevated levels of natriuretic peptides in patients with pulmonary thromboembolism. Respir Med 99:1286–1291

    Article  PubMed  Google Scholar 

  26. Kucher N, Printzen G, Goldhaber SZ (2003) Prognostic role of brain natriuretic peptide in acute pulmonary embolism. Circulation 107:2545–2547

    Article  PubMed  CAS  Google Scholar 

  27. Ray P, Maziere F, Medimagh S, Lefort Y, Arthaud M, Duguet A, Teixeira A, Riou B (2006) Evaluation of B-type natriuretic peptide to predict complicated pulmonary embolism in patients aged 65 years and older: brief report. Am J Emerg Med 24:603–607

    Article  PubMed  Google Scholar 

  28. Ten Wolde M, Tulevski II, Mulder JWM, Sohne M, Boomsma F, Mulder BJM, Buller HR (2003) Brain natriuretic peptide as a predictor of adverse outcome in patients with pulmonary embolism. Circulation 107:2082–2084

    Article  PubMed  CAS  Google Scholar 

  29. Tulevski II, Ten Wolde M, van Veldhuisen DJ, Mulder JW, van der Wall EE, Buller HR, Mulder BJ (2007) Combined utility of brain natriuretic peptide and cardiac troponin T may improve rapid triage and risk stratification in normotensive patients with pulmonary embolism. Int J Cardiol 116:161–166

    Article  PubMed  Google Scholar 

  30. Kruger S, Graf J, Merx MW, Koch KC, Kunz D, Hanrath P, Janssens U (2004) Brain natriuretic peptide predicts right heart failure in patients with acute pulmonary embolism. Am Heart J 147:60–65

    Article  PubMed  CAS  Google Scholar 

  31. Logeart D, Lecuyer L, Thabut G, Tabet JY, Tartiere JM, Chavelas C, Bonnin F, Stievenart JL, Solal AC (2007) Biomarker-based strategy for screening right ventricular dysfunction in patients with non-massive pulmonary embolism. Intensive Care Med 33:286–292

    Article  PubMed  CAS  Google Scholar 

  32. Pieralli F, Olivotto I, Vanni S, Conti A, Camaiti A, Targioni G, Grifoni S, Berni G (2006) Usefulness of bedside testing for brain natriuretic peptide to identify right ventricular dysfunction and outcome in normotensive patients with acute pulmonary embolism. Am J Cardiol 97:1386–1390

    Article  PubMed  CAS  Google Scholar 

  33. Binder L, Pieske B, Olschewski M, Geibel A, Klostermann B, Reiner C, Konstantinides S (2005) N-terminal pro-brain natriuretic peptide or troponin testing followed by echocardiography for risk stratification of acute pulmonary embolism. Circulation 112:1573–1579

    Article  PubMed  CAS  Google Scholar 

  34. Kostrubiec M, Pruszczyk P, Kaczynska A, Kucher N (2007) Persistent NT-proBNP elevation in acute pulmonary embolism predicts early death. Clin Chim Acta 382:124–128

    Article  PubMed  CAS  Google Scholar 

  35. Kostrubiec M, Pruszczyk P, Bochowicz A, Pacho R, Szulc M, Kaczynska A, Styczynski G, Kuch-Wocial A, Abramczyk P, Bartoszewicz Z, Berent H, Kuczynska K (2005) Biomarker-based risk assessment model in acute pulmonary embolism. Eur Heart J 26:2166–2172

    Article  PubMed  CAS  Google Scholar 

  36. Puls M, Dellas C, Lankeit M, Olschewski M, Binder L, Geibel A, Reiner C, Schafer K, Hasenfuss G, Konstantinides S (2007) Heart-type fatty acid-binding protein permits early risk stratification of pulmonary embolism. Eur Heart J 28:224–229

    Article  PubMed  CAS  Google Scholar 

  37. Kucher N, Printzen G, Doernhoefer T, Windecker S, Meier B, Hess OM (2003) Low pro-brain natriuretic peptide levels predict benign clinical outcome in acute pulmonary embolism. Circulation 107:1576–1578

    Article  PubMed  Google Scholar 

  38. Pruszczyk P, Kostrubiec M, Bochowicz A, Styczynski G, Szulc M, Kurzyna M, Fijalkoska A, Kuch-Wocial A, Chlewicka I, Torbicki A (2003) N-terminal pro-brain natriuretic peptide in patients with acute pulmonary embolism. Eur Respir J 22:649–653

    Article  PubMed  CAS  Google Scholar 

  39. Vuilleumier N, Righini M, Perrier A, Rosset A, Turck N, Sanchez JC, Bounameaux H, Le Gal G, Mensi N, Hochstrasser D (2007) Correlation between cardiac biomarkers and right ventricular enlargement on chest CT in non massive pulmonary embolism. Thromb Res 121:617–624

    Article  PubMed  CAS  Google Scholar 

  40. Wood KE (2002) Major pulmonary embolism: review of a pathophysiologic approach to the golden hour of hemodynamically significant pulmonary embolism. Chest 121:877–905

    Article  PubMed  Google Scholar 

  41. Goldhaber SZ (2004) Pulmonary embolism. Lancet 363:1295–1305

    Article  PubMed  Google Scholar 

  42. Tulevski II, Mulder BJ, van Veldhuisen DJ (2002) Utility of a BNP as a marker for RV dysfunction in acute pulmonary embolism. J Am Coll Cardiol 39:2080

    Article  PubMed  Google Scholar 

  43. Ribeiro A, Lindmarker P, Juhlin-Dannfelt A, Johnsson H, Jorfeldt L (1997) Echocardiography Doppler in pulmonary embolism: right ventricular dysfunction as a predictor of mortality rate. Am Heart J 134:479–487

    Article  PubMed  CAS  Google Scholar 

  44. Kucher N, Rossi E, De Rosa M, Goldhaber SZ (2005) Prognostic role of echocardiography among patients with acute pulmonary embolism and a systolic arterial pressure of 90 mm hg or higher. Arch Intern Med 165:1777–1781

    Article  PubMed  Google Scholar 

  45. Vieillard-Baron A, Page B, Augarde R, Prin S, Qanadli S, Beauchet A, Dubourg O, Jardin F (2001) Acute cor pulmonale in massive pulmonary embolism: incidence, echocardiographic pattern, clinical implications and recovery rate. Intensive Care Med 27:1481–1486

    Article  PubMed  CAS  Google Scholar 

  46. Becattini C, Vedovati MC, Agnelli G (2007) Prognostic value of troponins in acute pulmonary embolism: a meta-analysis. Circulation 116:427–433

    Article  PubMed  CAS  Google Scholar 

  47. Goldhaber SZ (2008) Assessing the prognosis of acute pulmonary embolism: tricks of the trade. Chest 133:334–336

    Article  PubMed  Google Scholar 

  48. Storch J, Thumser AE (2000) The fatty acid transport function of fatty acid-binding proteins. Biochim Biophys Acta 1486:28–44

    PubMed  CAS  Google Scholar 

  49. Goetze JP, Gore A, Moller CH, Steinbruchel DA, Rehfeld JF, Nielsen LB (2004) Acute myocardial hypoxia increases BNP gene expression. FASEB J 18:1928–1930

    PubMed  CAS  Google Scholar 

  50. Sohne M, Ten Wolde M, Buller HR (2004) Biomarkers in pulmonary embolism. Curr Opin Cardiol 19:558–562

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We thank Drs. David G. Kiely and Filippo Pieralli for providing additional information on their respective studies.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Paul E. Marik.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cavallazzi, R., Nair, A., Vasu, T. et al. Natriuretic peptides in acute pulmonary embolism: a systematic review. Intensive Care Med 34, 2147–2156 (2008). https://doi.org/10.1007/s00134-008-1214-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-008-1214-5

Keywords

Navigation